SFA
Souders Financial Advisors Portfolio holdings
AUM
$786M
This Quarter Return
+0.7%
1 Year Return
+13.91%
3 Year Return
+49.31%
5 Year Return
+87.49%
10 Year Return
–
AUM
$310M
AUM Growth
+$310M
(+4.5%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
4.23%
Top 10 Holdings %
Top 10 Hldgs %
38.41%
Holding
143
New
11
Increased
99
Reduced
15
Closed
8
Top Buys
| 1 |
T. Rowe Price Blue Chip Growth ETF
TCHP
|
$3.39M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$860K |
| 3 |
Procter & Gamble
PG
|
$816K |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$783K |
| 5 |
Amplify CWP Enhanced Dividend Income ETF
DIVO
|
$699K |
Top Sells
| 1 |
Lockheed Martin
LMT
|
$849K |
| 2 |
Teva Pharmaceuticals
TEVA
|
$830K |
| 3 |
Alibaba
BABA
|
$794K |
| 4 |
Corpay
CPAY
|
$517K |
| 5 |
Lufax Holding
LU
|
$450K |
Sector Composition
| 1 | Financials | 11% |
| 2 | Technology | 10.63% |
| 3 | Healthcare | 8.2% |
| 4 | Consumer Staples | 6.88% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Exxon Mobil
XOM
$487B
| $225K | 0.07% |
3,833
-106
| -3% | -$6.22K |
|
127
Qualcomm
QCOM
$173B
| $220K | 0.07% |
1,703
-117
| -6% | -$15.1K |
|
128
AT&T
T
$209B
| $217K | 0.07% |
8,023
+361
| +5% | +$9.76K |
|
129
Eli Lilly
LLY
$657B
| $209K | 0.07% |
906
| – | – |
|
130
Thermo Fisher Scientific
TMO
$186B
| $206K | 0.07% |
+360
| New | +$206K |
|
|
DFS
131
DELISTED
Discover Financial Services
DFS
| $204K | 0.07% |
+1,661
| New | +$204K |
|
132
AstraZeneca
AZN
$248B
| $201K | 0.06% |
+3,355
| New | +$201K |
|
|
XHR
133
Xenia Hotels & Resorts
XHR
$1.35B
| $200K | 0.06% |
11,281
-2,265
| -17% | -$40.2K |
|
134
SiriusXM
SIRI
$7.96B
| $62K | 0.02% |
10,118
| – | – |
|
135
KORU Medical Systems
KRMD
$195M
| $43K | 0.01% |
15,075
| – | – |
|
|
136
Alibaba
BABA
$322B
| – | – |
-3,502
| Closed | -$794K |
|
137
GE Aerospace
GE
$292B
| – | – |
-11,120
| Closed | -$150K |
|
138
SPDR Gold Trust
GLD
$107B
| – | – |
-1,451
| Closed | -$240K |
|
|
139
Lockheed Martin
LMT
$106B
| – | – |
-2,244
| Closed | -$849K |
|
|
140
Lufax Holding
LU
$2.55B
| – | – |
-39,795
| Closed | -$450K |
|
141
Cassava Sciences
SAVA
$110M
| – | – |
-3,116
| Closed | -$266K |
|
|
142
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
-83,821
| Closed | -$830K |
|
|
143
Corpay
CPAY
$23B
| – | – |
-2,020
| Closed | -$517K |
|